Coronary CTO PCI Using Antegrade Wiring Strategy With a First-choice Gladius Guidewire (Gladius First)
Launched by NATIONAL INSTITUTE OF CARDIOLOGY, WARSAW, POLAND · Dec 30, 2020
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • delivery of an informed consent and compliance with study protocol
- • CTO of a major coronary artery with at least intermediate difficulty score (J-CTO ≥1) as assessed by invasive angiography
- • referral to clinically indicated CTO PCI with intended primary antegrade wiring strategy
- Exclusion Criteria:
- • in-stent CTO
- • unstable angina and/or myocardial infarction
- • prior myocardial infarction within 4 weeks before study enrolment
- • CTO of a major coronary artery with an easy difficulty score (J-CTO 0) as assessed by invasive coronary angiography
- • lack of valid antegrade wire escalation strategy as assessed by 2 independent CTO PCI operators
- • chronic kidney disease (defined as eGFR ≤30 ml/min/m2)
- • contraindication to antiplatelet therapy and/or heparin
- • severe inflammatory disease
- • positive pregnancy test or breast-feeding
About National Institute Of Cardiology, Warsaw, Poland
The National Institute of Cardiology in Warsaw, Poland, is a leading research institution dedicated to advancing the understanding and treatment of cardiovascular diseases. Renowned for its commitment to innovative clinical research, the Institute focuses on improving patient outcomes through comprehensive studies that encompass prevention, diagnosis, and therapeutic strategies. With a multidisciplinary team of experts and state-of-the-art facilities, the National Institute of Cardiology plays a pivotal role in contributing to global cardiovascular knowledge and enhancing clinical practices in the field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Warsaw, , Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials